Author: Per Lundström
Posts by Per Lundström
Publication on model-informed drug development of CAR-T cell therapy
“This therapy has significantly transformed the treatment of aggressive hematological malignancies.” explains Anna Mc Laughlin, “However, despite its success, up to 60% of patients do not respond long-term. Alternative approaches beyond dose titration are required to increase exposure”
Pharmetheus workshops at ACoP 2023. Read more and sign up here.
Inspiring and empowering students to get into pharmacometrics
This year’s Educational Pharmacometrics Summer Symposium (EPSS) is taking place in conjunction with the PAGE 2023 meeting in A Coruña, Spain. The EPSS is a satellite event, mainly intended for Master’s and PhD students interested in learning more about pharmacometrics.
No giveaways for Pharmetheus at PAGE – instead we pay it forward
There will be no giveaways at the exhibition booth when Pharmetheus participates in PAGE 2023 . Instead, Pharmetheus donates its entire giveaway fund to selected causes resonating well with the company’s CSR goals, and challenges others to do the same.
Pharmetheus’ fit-for-purpose approach to meeting client needs
Pharmetheus started by offering pharmacometrics services that use mathematical and statistical models based on data in all phases of the drug development process. We talked with Elodie Plan and Marylore Chenel, both Principal Consultants and Team Leaders at Pharmetheus, to learn more about how the company’s offering has developed over time and how the company keeps up with state of the art methodologies.
A new visual identity as we enter our second decade
The new visual identity includes a new logo, updated colors of our
reports, and marketing and communication materials. We go live with a completely new
website, with a new graphic design, and new content showcasing our services and solutions in a more informative way.